To further enhance anti-tumor efficacy, VVL-GL21 was created using CRISPR/Cas9-based homologous recombination to insert the GM-CSF or IL-21 gene into the TK or A49 region of the VVL genome (22, 26). This evidence concerns the gene IL21 and neoplasm.